MELA Sciences to Host Investor Meeting May 7, 2012 in New York
(firmenpresse) - IRVINGTON, NY -- (Marketwire) -- 04/23/12 -- (NASDAQ: MELA), the medical device company that has developed ®, today announced that it will host a meeting for investors and analysts on Monday, May 7, 2012, 10-11 AM ET in New York City.
Joseph V. Gulfo, MD, MELA Sciences President and CEO, will host the meeting and provide a brief introduction and business update. He will then moderate a panel discussion and presentations from leading dermatologists. The clinicians will discuss their current practice patterns, the clinical utility of MelaFind and how they are incorporating it into their practice as well as the product's potential market opportunity. Following the presentations, there will be a question and answer session.
Space is limited, those interested in attending should RSVP to Lynn Pieper at .
A live audio webcast and slides of the MELA Sciences Investor Meeting will be accessible through the investor relations section of the Company's website at . An archived edition of the presentation will be available later that day and will be available for at least 90 days afterwards.
MELA Sciences is a medical device company focused on the commercialization of its flagship product, MelaFind®, and its further design and development. MelaFind is a non-invasive tool to provide additional information to dermatologists during melanoma skin examinations. The device uses light from visible to near-infrared wavelengths to evaluate skin lesions up to 2.5 mm beneath the skin. The device provides information on a lesion's level of morphologic disorganization to provide additional objective information that may be used by dermatologists in the biopsy decision-making process. MelaFind has been approved by the US Food and Drug Administration for use in the US. In addition, MelaFind has received CE Mark approval and is approved for use in the European Union.
For more information on MELA Sciences, visit .
For further information contact:
Lynn Pieper
Westwicke Partners
415-202-5678
Melissa Hurley
Ricochet Public Relations
212-679-3300 x128
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.04.2012 - 12:00 Uhr
Sprache: Deutsch
News-ID 137813
Anzahl Zeichen: 0
contact information:
Town:
IRVINGTON, NY
Kategorie:
Medical Devices
Diese Pressemitteilung wurde bisher 197 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MELA Sciences to Host Investor Meeting May 7, 2012 in New York"
steht unter der journalistisch-redaktionellen Verantwortung von
MELA Sciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
